Pharmaceuticals & Biotech Knowledge Center
Explore our verified library of Pharmaceuticals & Biotech transactions. Every entry is reviewed for IFRS compliance and real-world accuracy by our technical accounting team.
Prescription Drug Revenue — Sale to Wholesaler
Recognizing revenue from the sale of a prescription medicine to a pharmaceutical wholesaler.
Gross-to-Net — Chargeback Provision
Accruing the expected chargeback obligation when a wholesaler sells product to a contracted customer at a price below WAC.
Gross-to-Net — Government Medicaid Rebate Provision
Accruing the mandatory Medicaid rebate obligation on prescription drug sales.
Gross-to-Net — Managed Care / PBM Rebate
Accruing rebates payable to pharmacy benefit managers and health insurance plans based on formulary positioning agreements.
Patient Copay Assistance Program Cost
Recording the cost of providing copay assistance to commercially insured patients filling branded prescriptions.
Gross-to-Net — Sales Returns Provision
Estimating and accruing the provision for product returns from wholesalers and pharmacies.
Cost of Goods Sold — Manufactured Product
Recording the cost of drugs manufactured in-house and transferred to finished goods inventory, then expensed on sale.
Active Pharmaceutical Ingredient (API) Inventory Purchase
Recording the purchase of a controlled API from a contract manufacturer for use in drug production.
Internal R&D Expense — Drug Discovery & Development
Recording the monthly R&D expenses for internal drug discovery and development programmes.
CRO Clinical Trial Cost — Phase III Study
Recording costs payable to a Contract Research Organisation managing a pivotal Phase III clinical trial.
Clinical Investigator Site Payment
Recording payments to clinical investigation sites and principal investigators for patient visits in a clinical trial.
Milestone Payment — In-Licensed Drug Compound
Recording a development milestone payment to a licensor when an in-licensed compound achieves Phase II proof-of-concept.
Royalty Income — Out-Licensed Product
Recording royalty income received from a licensee selling a product that uses the company's intellectual property.
Upfront License Fee — Deferred Revenue
Recording an upfront payment received from a licensee for the right to develop and commercialize a drug compound.
Development Milestone Received — Out-License
Recognizing a regulatory approval milestone payment received from a licensee.
Acquired Drug Patent — Intangible Asset Capitalisation
Capitalizing the cost of a purchased drug patent following regulatory approval of the drug.
Drug Patent — Monthly Amortisation
Monthly amortisation of an approved drug's capitalised patent value over its remaining useful life.
In-Process R&D — Acquisition of Pre-Approval Asset
Expensing the fair value allocated to in-process research and development in a pharma acquisition.
Regulatory Filing Fee — NDA/BLA/MAA Submission
Recording the regulatory user fee paid to the FDA (or EMA/other agency) upon filing a new drug application.
Business Combination — Goodwill Recognition
Recording goodwill arising from the acquisition of a pharmaceutical company.
Contingent Value Right (CVR) — Fair Value Remeasurement
Remeasuring the fair value of a CVR liability issued to the selling shareholders of an acquired biotech company.
Manufacturing Batch Failure Write-Off
Writing off the cost of a batch of drug product that failed quality testing and must be destroyed.
Product Liability Provision
Recognising a provision for expected litigation costs arising from product liability claims related to adverse drug reactions.
Drug Product Recall — Provision and Costs
Recognizing a provision for the costs of a voluntary or mandatory drug product recall.
Market Access Rebate — Hospital Formulary Agreement
Recording volume-based rebates payable to hospital networks for formulary inclusion.
Specialty Pharmacy Data and Distribution Fee
Recording fees paid to specialty pharmacies for patient data, adherence services, and preferred distribution status.
Orphan Drug Tax Credit (ODC) — R&D Tax Credit
Recognizing a tax credit for qualifying clinical trial expenses on a drug with orphan designation.
Contract Manufacturing (CMO) — Supply Agreement Cost
Recording the monthly cost of drug substance and drug product manufactured under a contract manufacturing agreement.
Sales Force Compensation and Incentives
Recording base salary and incentive compensation for pharmaceutical sales representatives.
Medical Affairs — KOL Advisory and Speaker Programme
Recording fees and expenses for Key Opinion Leader (KOL) advisory boards, speaker programmes, and medical education activities.
Pre-Launch Inventory — PDUFA Date Manufacturing
Recording the accounting treatment of drug product manufactured ahead of FDA approval in anticipation of a commercial launch.
Stacked Royalties — Multiple IP Licensor Obligations
Recording multiple royalty obligations payable to different patent holders whose IP is incorporated in a biologic drug.
Compassionate Use / Expanded Access Program Cost
Recording the cost of providing drug product free of charge under an expanded access programme before regulatory approval.
Deferred Tax Liability — Acquired Drug Intangibles (PPA)
Recording the deferred tax liability arising from the fair value step-up of acquired drug intangibles in a business combination.
Transfer Pricing — Intercompany Drug Product Sale
Recording the intercompany sale of finished drug product from the manufacturing subsidiary to the selling affiliate.
Clinical Trial Supply Write-Off — Study Termination
Writing off unused clinical trial drug supply when a clinical programme is discontinued.
Direct-to-Consumer (DTC) Advertising Campaign
Recording the cost of a national DTC advertising campaign for a branded prescription drug.
EOSB Provision — Pharma Staff (Jordan Operations)
Accruing end-of-service benefits for employees of a pharmaceutical company's Jordanian operations.
GST / VAT on Pharmaceutical Sales (Jordan)
Recording the VAT treatment of pharmaceutical sales in Jordan — exempt vs. taxable products.
Import Duty and Customs Clearance — Drug Product
Recording customs duties and clearance costs on imported pharmaceutical products.
Pharmacovigilance (Safety Monitoring) Expense
Recording the ongoing cost of post-marketing drug safety surveillance and adverse event reporting.
Need a specific Pharmaceuticals & Biotech entry?
Our team is constantly updating the hub. If you can't find what you need, suggest a new entry below.
Contact Expert